34-51-2. Eligible patient defined.

For the purposes of this chapter, the term, eligible patient, means a patient who meets all the following qualifications:

(1)    Has an advanced illness, attested by the patient's treating physician;

(2)    Has considered all other treatment options currently approved by the United States Food and Drug Administration;

(3)    Has received a recommendation from the patient's treating physician for an investigational drug, biological product, or device;

(4)    Has given written, informed consent for the use of the investigational drug, biological product, or device; and

(5)    Has documentation from the patient's treating physician that the patient meets requirements pursuant to this chapter.

Source: SL 2015, ch 188, § 2.